30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q14 Revenue: RTI Surgical

$46.0MM, +77% (includes $19.8MM from Pioneer Surgical)

  • Spine $19.0MM, +89%
  • Bone Graft Substitutes/General Orthopaedic $8.1MM, +52%
  • Sports Medicine $11.3MM, +8%
  • Ortho Fixation $7.4MM


  • Product launches included map3 cellular allogeneic bone graft, MaxFuse VBR, Aspect Anterior Cervical Plate, nanOss Bioactive 3D
  • Renewed supply/distribution agreement with Zimmer for trauma products
  • Added >30 new customers in spine
  • Brought back >100 sports medicine accounts (1/3 new, 2/3 converted from autograft)